$1.4 Billion is the total value of First Light Asset Management, LLC's 79 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EBS | Exit | EMERGENT BIOSOLUTIONS INC | $0 | – | -4,294 | -100.0% | -0.01% | – |
| HRC | Exit | HILL ROM HOLDINGS | $0 | – | -4,346 | -100.0% | -0.04% | – |
| RLAY | Exit | RELAY THERAPEUTICS INC | $0 | – | -51,848 | -100.0% | -0.11% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -620,887 | -100.0% | -0.35% | – |
| NVTA | Exit | INVITAE CORPORATION | $0 | – | -256,367 | -100.0% | -0.48% | – |
| WW | Exit | WW INTERNATIONAL INC | $0 | – | -458,273 | -100.0% | -0.55% | – |
| Exit | APTOSE BIOSCIENCES INC | $0 | – | -4,128,443 | -100.0% | -0.59% | – | |
| STIM | Exit | NEURONETICS INC | $0 | – | -1,458,818 | -100.0% | -0.63% | – |
| YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -577,663 | -100.0% | -1.09% | – |
| XBI | Exit | SPDR S&P BIOTECH ETF | $0 | – | -204,600 | -100.0% | -1.70% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -2,985,712 | -100.0% | -1.73% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 40 | Q3 2023 | 9.7% |
| NEOGENOMICS INC | 40 | Q3 2023 | 10.6% |
| SANOFI-SYNTHELABO | 40 | Q3 2023 | 1.9% |
| JOHNSON & JOHNSON | 40 | Q3 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 36 | Q3 2023 | 1.6% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| NOVARTIS AG-SPONSORED ADR | 33 | Q3 2023 | 0.4% |
| MODEL N INC | 30 | Q3 2023 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| REATA PHARMACEUTICALS INC | May 15, 2023 | 1,290,193 | 3.9% |
| Axogen, Inc. | February 03, 2023 | 1,942,270 | 4.6% |
| MODEL N, INC. | February 03, 2023 | 1,845,134 | 4.9% |
| MEI Pharma, Inc.Sold out | May 31, 2022 | 0 | 0.0% |
| PROTHENA CORP PUBLIC LTD CO | March 01, 2022 | 1,805,038 | 3.9% |
| Intersect ENT, Inc. | February 14, 2022 | 1,375,210 | 4.1% |
| SeaSpine Holdings Corp | February 14, 2022 | 6,847,707 | 18.8% |
| Oxford Immunotec Global PLCSold out | February 10, 2021 | 0 | 0.0% |
| ENDOLOGIX INC /DE/ | February 14, 2020 | 816,236 | 4.6% |
| Nuvectra CorpSold out | February 14, 2020 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.